Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · IEX Real-Time Price · USD

0.620

-0.044 (-6.70%)

At close: Jul 19, 2024, 12:00 AM

0.640

+0.020 (3.23%)

Pre-market: Jul 22, 2024, 9:13 AM EDT

Quoin Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Market Capitalization	2	5	7	15	8	5	Upgrade
Market Cap Growth	-37.85%	-29.64%	-54.71%	79.96%	69.77%	-60.57%	Upgrade
Enterprise Value	-2	-6	-6	8	9	-0	Upgrade
PE Ratio	-	-0.56	-0.73	-0.71	-4.03	-3.19	Upgrade
PB Ratio	0.94	0.86	0.93	23.13	-1.28	1.09	Upgrade
P/FCF Ratio	-0.46	-0.62	-0.79	-2.40	-5.77	-3.83	Upgrade
P/OCF Ratio	-0.46	-0.62	-0.81	-2.66	-6.31	-3.83	Upgrade
EV/EBITDA Ratio	1.35	0.68	0.70	-0.39	-4.80	0.18	Upgrade
EV/EBIT Ratio	1.33	0.67	0.69	-0.38	-4.56	0.18	Upgrade
EV/FCF Ratio	1.48	0.74	0.68	-1.22	-6.38	0.22	Upgrade
Debt / Equity Ratio	-	-	-	-	-0.18	0.07	Upgrade
Debt / EBITDA Ratio	-	-	-	-	-0.62	-0.22	Upgrade
Debt / FCF Ratio	-	-	-	-	-0.83	-0.25	Upgrade
Quick Ratio	3.48	2.99	3.64	1.64	0.04	5.14	Upgrade
Current Ratio	3.61	3.15	3.79	1.79	0.06	5.11	Upgrade
Interest Coverage	-	-	-12.14	-14.72	-43.56	-	Upgrade
Return on Equity (ROE)	-107.60%	-105.10%	-296.00%	721.40%	-64.60%	-26.20%	Upgrade
Return on Assets (ROA)	-56.00%	-55.70%	-89.20%	-399.90%	-32.20%	-17.30%	Upgrade
Return on Capital (ROIC)	-99.30%	-165.58%	-124.99%	-922.76%	30.96%	-31.78%	Upgrade
Earnings Yield	-357.37%	-179.39%	-136.32%	-141.23%	-24.81%	-31.37%	Upgrade
FCF Yield	-88.03%	-162.41%	-126.86%	-41.75%	-17.33%	-26.11%	Upgrade
Buyback Yield / Dilution	-273.37%	-144.43%	98.47%	-31.42%	-	-928242.65%	Upgrade
Total Shareholder Return	-273.37%	-144.43%	98.47%	-31.42%	-	-928242.65%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).